Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for RXRX

Stock NameRecursion Pharmaceuticals Inc
TickerRXRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75629V1044

Show aggregate RXRX holdings

News associated with RXRX

Nvidia Has $4.3 Billion Invested in These 6 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch.
Key PointsNvidia owned six AI stocks at the end of Q2. - 2025-09-15 05:44:00
When You Buy Nvidia Stock, You Get a Bonus: An Artificial Intelligence (AI) ETF of Sorts
Key PointsNvidia's largest stock holding is CoreWeave, which has more than doubled since its March IPO. - 2025-09-03 07:00:00
3 AI Stocks Disrupting Trillion-Dollar Industries
Key PointsPalantir's artificial intelligence (AI) platform generates 46% operating margins, while being embedded so deeply in government operations that switching vendors would take decades. - 2025-09-02 09:45:00
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.
Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 9.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,864 shares of the company’s stock after acquiring an additional 2,587 shares during […] - 2025-08-15 04:46:57
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) have earned an average rating of “Hold” from the six analysts that are presently covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price […] - 2025-08-13 02:28:44
Blair William & Co. IL Raises Stock Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Blair William & Co. IL lifted its stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 854.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 114,500 shares of the company’s stock after buying an additional 102,500 shares during the quarter. […] - 2025-08-11 05:52:57
How The Parts Add Up: ESGV Targets $123
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-06 08:04:45
Pre-Market Most Active for Aug 5, 2025 : OPEN, AIP, TSLL, PFE, RXRX, PLTR, SQQQ, HIMS, BBAI, NIO, FIG, JOBY
The NASDAQ 100 Pre-Market Indicator is up 64.21 to 23,252.82. The total Pre-Market volume is currently 183,775,922 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.0191 at $2.48, with 7,136,575 shares trade - 2025-08-05 09:29:57
Cerity Partners LLC Invests $332,000 in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Cerity Partners LLC purchased a new position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) during the first quarter, Holdings Channel reports. The fund purchased 62,691 shares of the company’s stock, valued at approximately $332,000. A number of other institutional investors have also recently made changes to their positions in the stock. GAMMA Investing LLC […] - 2025-07-28 04:28:49
The Median Retirement Savings for American Households Is $87,000. Here Are 3 Incredible Stocks to Buy Now and Hold for Decades.
Key PointsArtificial intelligence-powered drug development isn't a mere premise anymore. Recursion Pharmaceuticals has made it a reality. - 2025-07-26 19:14:00
3 AI Stocks Partnered With Nvidia With Massive Growth Opportunities
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and other artificial intelligence stocks with which Nvidia has either a partnership or owns shares. To learn more, check out the short video, consider subscribing, and click the special offer link below. - 2025-07-23 11:07:27
Pre-Market Most Active for Jul 22, 2025 : OPEN, TSLL, REPL, SQQQ, OSCR, NVDA, QS, RXRX, BBAI, JOBY, NIO, CVX
The NASDAQ 100 Pre-Market Indicator is down -5.34 to 23,174.72. The total Pre-Market volume is currently 168,215,532 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.62 at $3.83, with 67,855,698 shares trad - 2025-07-22 09:29:55
Stratos Wealth Partners LTD. Has $63,000 Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Stratos Wealth Partners LTD. decreased its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 27.7% during the 1st quarter, Holdings Channel reports. The firm owned 11,974 shares of the company’s stock after selling 4,579 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Recursion Pharmaceuticals were worth $63,000 at the end of […] - 2025-07-18 04:34:52
D.A. Davidson & CO. Raises Stock Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
D.A. Davidson & CO. boosted its position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 571.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 107,432 shares of the company’s stock after acquiring an additional 91,438 […] - 2025-07-11 05:26:53
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Bought by GAMMA Investing LLC
GAMMA Investing LLC grew its stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 39.0% in the first quarter, according to its most recent filing with the SEC. The fund owned 7,224 shares of the company’s stock after acquiring an additional 2,026 shares during the period. GAMMA Investing LLC’s holdings in Recursion […] - 2025-07-11 04:45:22
Wealth Enhancement Advisory Services LLC Raises Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Wealth Enhancement Advisory Services LLC raised its stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 27.8% in the 1st quarter, HoldingsChannel.com reports. The firm owned 24,230 shares of the company’s stock after buying an additional 5,278 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Recursion Pharmaceuticals were worth $128,000 as […] - 2025-07-11 04:08:55
Recursion Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:RXRX)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) saw unusually large options trading activity on Wednesday. Stock investors bought 29,275 call options on the company. This is an increase of approximately 43% compared to the average daily volume of 20,478 call options. Recursion Pharmaceuticals Price Performance NASDAQ RXRX opened at $5.72 on Friday. The company […] - 2025-07-11 02:18:48
Recursion Pharmaceuticals: The AI Drug Discovery Play
Recursion Pharmaceuticals (NASDAQ:RXRX) has seen significant share price volatility in 2025, dropping 27% year-to-date and trading over 55% below its 52-week high of $12. Despite this underperformance, the clinical-stage TechBio company continues to garner attention for its innov - 2025-07-08 23:56:11
Here's Why Shares in Recursion Pharmaceuticals Surged Today
Key PointsRecursion Pharmaceuticals is now the sole owner of a drug in its pipeline. - 2025-07-08 14:28:49
The Hottest 10 Artificial Intelligence (AI) Stocks on the Market
Key PointsHardware is only one piece of the artificial intelligence platform puzzle. - 2025-07-08 07:00:00
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives $7.00 Average Price Target from Analysts
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) have been given a consensus recommendation of “Hold” by the six research firms that are presently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month […] - 2025-06-27 02:10:58
Morgan Stanley Has Lowered Expectations for Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price
Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) had its target price cut by analysts at Morgan Stanley from $8.00 to $5.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s target price indicates a potential upside of 3.31% from the stock’s previous close. Several […] - 2025-06-18 02:50:50
Azzad Asset Management Inc. ADV Raises Stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Azzad Asset Management Inc. ADV boosted its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 21.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,811 shares of the company’s stock after buying an additional 2,982 shares during the period. […] - 2025-06-16 05:54:48
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Purchased by Integrated Advisors Network LLC
Integrated Advisors Network LLC boosted its holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 17.1% during the 1st quarter, Holdings Channel reports. The fund owned 20,603 shares of the company’s stock after acquiring an additional 3,015 shares during the quarter. Integrated Advisors Network LLC’s holdings in Recursion Pharmaceuticals were worth $109,000 as of […] - 2025-06-16 05:05:20
California State Teachers Retirement System Acquires 54,449 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
California State Teachers Retirement System boosted its stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 30.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 231,535 shares of the company’s stock after acquiring an additional 54,449 shares during the quarter. […] - 2025-06-09 04:43:00
Squarepoint Ops LLC Takes Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Squarepoint Ops LLC bought a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 80,421 shares of the company’s stock, valued at approximately $544,000. A number of other institutional investors also […] - 2025-06-04 05:48:48
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Average Rating of “Hold” from Analysts
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) have earned a consensus rating of “Hold” from the six research firms that are covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective […] - 2025-05-30 02:10:57
Two Sigma Advisers LP Has $3.05 Million Stock Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Two Sigma Advisers LP trimmed its position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 7.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 451,745 shares of the company’s stock after selling 38,155 shares during the quarter. Two Sigma Advisers LP’s holdings in Recursion Pharmaceuticals were worth $3,054,000 as of […] - 2025-05-27 05:57:01
Man Group plc Makes New $479,000 Investment in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Man Group plc bought a new position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, HoldingsChannel reports. The fund bought 70,802 shares of the company’s stock, valued at approximately $479,000. Several other hedge funds also recently bought and sold shares of RXRX. Private Trust Co. NA purchased a new […] - 2025-05-27 04:59:05
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Sold by Cresset Asset Management LLC
Cresset Asset Management LLC lessened its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 64.6% during the fourth quarter, HoldingsChannel reports. The fund owned 25,029 shares of the company’s stock after selling 45,663 shares during the period. Cresset Asset Management LLC’s holdings in Recursion Pharmaceuticals were worth $169,000 at the end […] - 2025-05-19 05:02:51

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc RXRX holdings

DateNumber of RXRX Shares HeldBase Market Value of RXRX SharesLocal Market Value of RXRX SharesChange in RXRX Shares HeldChange in RXRX Base ValueCurrent Price per RXRX Share HeldPrevious Price per RXRX Share Held
2025-09-30 (Tuesday)97,069USD 473,697USD 473,697
2025-09-29 (Monday)96,441USD 473,525USD 473,525
2025-09-26 (Friday)96,441USD 455,202USD 455,202
2025-09-25 (Thursday)96,441USD 446,522RXRX holding decreased by -24110USD 446,5220USD -24,110 USD 4.63 USD 4.88
2025-09-24 (Wednesday)96,441USD 470,632USD 470,632
2025-09-17 (Wednesday)95,815USD 451,289RXRX holding decreased by -12456USD 451,2890USD -12,456 USD 4.71 USD 4.84
2025-09-16 (Tuesday)95,815USD 463,745USD 463,745
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RXRX by Blackrock for IE00B3VWM098

Show aggregate share trades of RXRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-11BUY1,252 4.850* 6.09
2025-08-21SELL-403 4.780* 6.10 Profit of 2,459 on sale
2025-07-31BUY1,206 5.950* 6.11
2025-06-30SELL-804 5.060* 6.17 Profit of 4,963 on sale
2025-06-25SELL-402 5.160* 6.19 Profit of 2,490 on sale
2025-06-20SELL-806 5.030* 6.22 Profit of 5,012 on sale
2025-05-30SELL-38,770 4.180* 6.37 Profit of 246,974 on sale
2025-05-23BUY537 4.080* 6.46
2025-05-19SELL-537 4.510* 6.53 Profit of 3,507 on sale
2025-05-15SELL-1,611 4.250* 6.57 Profit of 10,581 on sale
2025-05-12SELL-537 4.640* 6.62 Profit of 3,557 on sale
2025-05-09SELL-537 4.330* 6.65 Profit of 3,569 on sale
2025-04-30SELL-537 5.590* 6.76 Profit of 3,632 on sale
2025-04-24SELL-1,074 5.750* 6.80 Profit of 7,308 on sale
2025-04-17SELL-537 5.500* 6.87 Profit of 3,691 on sale
2025-04-15SELL-1,611 5.640* 6.90 Profit of 11,121 on sale
2025-04-14SELL-1,611 5.510* 6.92 Profit of 11,146 on sale
2025-04-09SELL-2,152 4.650* 6.98 Profit of 15,031 on sale
2025-04-07SELL-3,766 4.200* 7.05 Profit of 26,558 on sale
2025-04-04SELL-5,380 4.240* 7.09 Profit of 38,119 on sale
2025-03-31BUY538 5.290* 7.15
2025-03-19SELL-1,078 6.580* 7.24 Profit of 7,802 on sale
2025-03-14SELL-3,234 6.350* 7.27 Profit of 23,503 on sale
2025-03-13SELL-1,080 5.940* 7.29 Profit of 7,869 on sale
2025-03-12SELL-18,360 6.170* 7.30 Profit of 134,073 on sale
2025-03-07SELL-1,080 6.590* 7.35 Profit of 7,938 on sale
2025-03-06SELL-1,623 6.240* 7.37 Profit of 11,957 on sale
2025-03-03SELL-541 6.590* 7.41 Profit of 4,007 on sale
2025-02-28BUY22,371 7.510* 7.40
2025-02-26SELL-473 8.340* 7.38 Profit of 3,493 on sale
2025-02-25SELL-1,419 8.140* 7.37 Profit of 10,460 on sale
2025-02-18BUY2,365 10.640* 7.12
2025-02-13BUY473 8.500* 6.96
2025-02-12BUY473 8.340* 6.93
2025-02-11BUY1,419 7.660* 6.91
2025-02-06BUY4,248 7.240* 6.88
2025-01-27BUY472 7.030* 6.76
2024-12-30BUY2,360 6.770* 6.71
2024-12-06BUY1,888 8.010* 6.59
2024-12-05BUY472 6.590* 6.59
2024-12-04BUY2,360 7.130* 6.57
2024-11-29BUY2,355 7.070* 6.48
2024-11-27BUY1,884 6.380* 6.49
2024-11-26BUY471 5.890* 6.52
2024-11-25BUY26,210 6.000* 6.55
2024-11-21BUY1,960 5.750* 6.63
2024-11-20BUY1,173 6.040* 6.66
2024-11-18BUY4,692 6.100* 6.72
2024-11-12BUY3,128 7.580* 6.67
2024-11-08BUY1,955 7.100* 6.64
2024-11-07BUY5,850 6.930* 6.61
2024-11-06BUY780 6.970* 6.58
2024-10-31BUY390 6.320* 6.60
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RXRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-196,394,71948,92515,980,01140.0%
2025-09-184,365,54563213,148,35033.2%
2025-09-176,737,2039,97715,686,81042.9%
2025-09-162,836,43928,1109,562,09129.7%
2025-09-154,765,80816,57710,328,93246.1%
2025-09-124,793,66723,2098,623,13055.6%
2025-09-117,339,78430,76316,222,89045.2%
2025-09-104,540,5026,4607,389,74261.4%
2025-09-092,207,5129975,995,52236.8%
2025-09-083,062,18814,0037,216,51342.4%
2025-09-052,547,61424,0787,410,29934.4%
2025-09-042,986,0453,6717,342,70240.7%
2025-09-033,384,3784,4157,068,61747.9%
2025-09-022,089,3902,3366,243,08533.5%
2025-08-294,257,19631,6598,523,15849.9%
2025-08-284,236,9217,3216,891,24361.5%
2025-08-273,810,5653,6646,459,81059.0%
2025-08-263,013,93017,1895,119,97258.9%
2025-08-255,239,02422,5718,104,57564.6%
2025-08-224,661,72223,86010,351,61345.0%
2025-08-214,217,6118,0347,166,40758.9%
2025-08-205,821,74715,89913,046,26044.6%
2025-08-194,076,00190,21610,761,65637.9%
2025-08-183,381,0265,9618,875,41238.1%
2025-08-152,500,1033,6207,638,69532.7%
2025-08-143,312,8934,1976,968,98947.5%
2025-08-135,744,20620,47411,400,15950.4%
2025-08-124,024,67513,4027,778,57151.7%
2025-08-114,942,134218,9309,084,53454.4%
2025-08-082,992,39911,7616,083,75249.2%
2025-08-073,235,48015,4286,265,11951.6%
2025-08-063,956,25388,2268,351,79447.4%
2025-08-059,215,90710,34416,251,83056.7%
2025-08-045,488,89512,57310,380,39152.9%
2025-08-015,081,28428,6698,831,78057.5%
2025-07-315,048,1221,73410,955,16446.1%
2025-07-305,139,72711,55411,918,37143.1%
2025-07-296,763,24120,36615,192,12144.5%
2025-07-289,079,72223,51915,743,32557.7%
2025-07-254,989,39914,47612,746,43439.1%
2025-07-247,368,10054,47512,874,85357.2%
2025-07-2313,433,51155,01322,760,75859.0%
2025-07-227,864,80150,75717,783,89244.2%
2025-07-2114,871,29974,88640,264,49036.9%
2025-07-1812,319,268105,77134,035,88236.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.